HIGHLIGHTS
- who: Shunlai Shang from the Agostino Gemelli University Polyclinic, (IRCCS), Italy have published the research: Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy, in the Journal: (JOURNAL)
- what: The authors focused on the treatment outcome of low-dose glucocorticoids combined with an immunosuppressant in patients with DKD+MN. This study showed no significant difference in hba1c between leflunomide combined with low-dose glucocorticoid and leflunomide alone, indicating that low-dose glucocorticoid has the least effect on blood glucose in DKD patients with MN. As a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.